|
|
||||||||
knockout mice after partial hepatectomy
1 Laboratory of Hepatobiology and Toxicology, Department of Pharmacology, 2 Curriculum in Toxicology, School of Medicine, and 3 School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27599; and 4 Institut fur Krebsforschung, A-1090 Vienna, Austria
Liver regeneration
after partial hepatectomy (PH) involves several signaling
mechanisms including activation of the small GTPases Ras and RhoA in
response to mitogens leading to DNA synthesis and cell proliferation.
Peroxisome proliferator-activated receptor-
(PPAR
) regulates the
expression of several key enzymes in isoprenoid synthesis, which are
key events for membrane association of Ras and RhoA. Thus the role of
PPAR
in cell proliferation after PH was tested. After PH, an
increase in PPAR
DNA binding was observed in wild-type mice,
correlating with an increase in the PPAR
-regulated enzyme acyl-CoA
oxidase. In addition, the PPAR
-regulated genes farnesyl
pyrophosphate synthase and 3-hydroxy-3-methylglutaryl-coenzyme A
(HMG-CoA) synthase were significantly increased in wild-type mice. However, these increases were not observed in PPAR
knockout (PPAR
/
) mice. The peak in DNA synthesis observed 42 h
after PH was reduced by ~60% in PPAR
/
mice, despite
increases in TNF-
and IL-1. Also, under these conditions, membrane
association of Ras was high in wild-type mice after PH but was impaired
in PPAR
/
mice. Accordingly, Ras was significantly elevated in the cytosol in PPAR
/
mice. This observation correlated with lower levels of active GTP-bound Ras after PH in PPAR
/
mice compared with wild-type mice. Similar observations were made for RhoA.
Moreover, deletion of PPAR
blunted the activation of
cyclin-dependent kinase (cdk)2/cyclin E and cdk4/cyclin D complexes.
Collectively, these results support the hypothesis that PPAR
is
necessary for cell cycle progression in regenerating mouse liver via
mechanisms involving prenylation of small GTPases Ras and RhoA.
hepatocyte proliferation; cell cycle regulation; RhoA; peroxisome
proliferation-activated receptor-
Deceased 14 July 2001.
This article has been cited by other articles:
![]() |
E. Arikawa, R. C.W. Ma, K. Isshiki, I. Luptak, Z. He, Y. Yasuda, Y. Maeno, M. E. Patti, G. C. Weir, R. A. Harris, et al. Effects of Insulin Replacements, Inhibitors of Angiotensin, and PKC{beta}'s Actions to Normalize Cardiac Gene Expression and Fuel Metabolism in Diabetic Rats Diabetes, May 1, 2007; 56(5): 1410 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. O. Conzelmann, I. N. Hines, M. Kremer, A. W. Perry, J. J. Lemasters, and M. D. Wheeler Extrahepatic Cells Contribute to the Progenitor/Stem Cell Response Following Reduced-Size Liver Transplantation in Mice Experimental Biology and Medicine, April 1, 2007; 232(4): 571 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Corton and H. M. Brown-Borg Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1 in Caloric Restriction and Other Models of Longevity J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1494 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Howroyd, C. Swanson, C. Dunn, R. C. Cattley, and J. C. Corton Decreased Longevity and Enhancement of Age-Dependent Lesions in Mice Lacking the Nuclear Receptor Peroxisome Proliferator-Activated Receptor {alpha} (PPAR{alpha}) Toxicol Pathol, August 1, 2004; 32(5): 591 - 599. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |